CO106 A Structured Expert Elicitation Exercise Conducted With UK Clinicians to Inform and Validate Inputs for a Cost-Effectiveness Analysis of FILSUVEZ ® Gel (Birch Bark Extract) in Epidermolysis Bullosa
Epidermolysis bullosa (EB) is a rare, chronic, genetic disorder characterised by skin fragility and blistering. Current standard of care (SoC), although heterogenous between patients, focuses on wound care, complication management, and improving quality of life. A structured expert elicitation (SEE) was conducted to inform key assumptions, validate data, and provide estimates for clinical and resource use parameters for a cost-effectiveness model (CEM), evaluating the impact of Filsuvez ® gel, licensed by EMA and MHRA, for treating partial thickness wounds in dystrophic EB (DEB) and junctional EB (JEB), in patients ≥6 months.
Source: Value in Health - Category: International Medicine & Public Health Authors: L. Stainer, S. Ryder, E. Carr, C. Collins, M. Arora, K. Tolley Source Type: research
More News: Epidermolysis Bullosa | Genetics | International Medicine & Public Health | Skin | Sports Medicine